Why Sarepta Therapeutics, Inc. Stock Jumped 18.8% Higher in August

The company’s only drug, Exondys 51, is selling well, but investors should be watching the pipeline. …read more

Source:: Yahoo Finance


Did you enjoy this article? Join our FREE Newsletter!
I agree to have my personal information transfered to MailChimp ( more information )
Join over 100,000 investors and business leaders worldwide. Get the latest actionable business and investing intelligence before the rest of the crowd.
We hate spam. Your email address will not be sold or shared with anyone else.